Medical Devices Stocks
Precision engineering and biological integration define this sector, where revenue stems from the sale of proprietary hardware, consumable components, and diagnostic monitoring systems used in clinical settings.
As of Oct 23, 2026, Medical Devices has 299 US-listed companies worth $3T combined. The median member moved +0.8% over the past week; ALC led among the 25 largest at +6.0% and DXCM trailed at -9.4%.
Companies in Medical Devices
- JNJ – Johnson & Johnson, $645B
- TMO – Thermo Fisher Scientific Inc, $249B
- ABT – Abbott Laboratories, $177B
- DHR – Danaher Corporation, $162B
- ISRG – Intuitive Surgical Inc, $160B
- MDT – Medtronic PLC, $122B
- SYK – Stryker Corporation, $118B
- MCK – McKesson Corporation, $117B
- BSX – Boston Scientific Corp, $66.7B
- CAH – Cardinal Health Inc, $59.2B
- NTRA – Natera Inc, $57.9B
- BDX – Becton Dickinson and Company, $54.6B
- EW – Edwards Lifesciences Corp, $51.9B
- MDLN – Medline Inc. Class A Common Stock, $45.9B
- WAT – Waters Corporation, $44.9B
- IDXX – IDEXX Laboratories Inc, $44.6B
- ILMN – Illumina Inc, $40.7B
- RMD – ResMed Inc, $35.6B
- ALC – Alcon AG, $34.1B
- ZTS – Zoetis Inc, $33.9B
- GEHC – GE HealthCare Technologies Inc., $32.5B
- DXCM – DexCom Inc, $29.6B
- WST – West Pharmaceutical Services Inc, $27.7B
- PHG – Koninklijke Philips NV ADR, $26.3B
- STE – STERIS plc, $22.6B
- GH – Guardant Health Inc, $21.9B
- ZBH – Zimmer Biomet Holdings Inc, $18.8B
- MEDP – Medpace Holdings Inc, $18.3B
- NDSN – Nordson Corporation, $17.8B
- SOLV – Solventum Corp., $14.9B
- NPXYY – Nippon Sanso Holdings Corp., $14.8B
- CRS – Carpenter Technology Corporation, $14.5B
- BAX – Baxter International Inc, $13.3B
- SNN – Smith & Nephew SNATS Inc, $12.9B
- PEN – Penumbra Inc, $12.8B
- FMS – Fresenius Medical Care Corporation, $11.8B
- COO – The Cooper Companies, Inc, $11.7B
- AVTR – Avantor Inc, $11.7B
- TECH – Bio-Techne Corp, $11.4B
- ALGN – Align Technology Inc, $11B
- GMED – Globus Medical, $10.9B
- GKOS – Glaukos Corp, $10.4B
- QGEN – Qiagen NV, $10.4B
- PODD – Insulet Corporation, $10.3B
- BIO – Bio-Rad Laboratories Inc, $9.6B
- HSIC – Henry Schein Inc, $9.6B
- BRKR – Bruker Corporation, $8.7B
- SANM – Sanmina Corporation, $8.3B
- ATR – AptarGroup Inc, $8.1B
- SHMXY – Shimadzu Corp, $7.6B
- LNTH – Lantheus Holdings Inc, $6.5B
- BLCO – Bausch + Lomb Corp, $6.2B
- GRAL – GRAIL, LLC, $5.7B
- TFX – Teleflex Incorporated, $5.5B
- STVN – Stevanato Group SpA, $5.5B
- RDNT – RadNet Inc, $5.5B
- HAE – Haemonetics Corporation, $5.4B
- MMSI – Merit Medical Systems Inc, $5.4B
- MMED – MiniMed Group, Inc. Common Stock, $5.2B
- SHC – Sotera Health Co, $5B
- NOVT – Novanta Inc, $5B
- HTFL – Heartflow, Inc. Common Stock, $4.4B
- ITGR – Integer Holdings Corp, $4.3B
- LIVN – LivaNova PLC, $4.3B
- ICUI – ICU Medical Inc, $4B
- TLX – Telix Pharmaceuticals Limited, $3.8B
- MIR – Mirion Technologies Inc, $3.7B
- NVST – Envista Holdings Corp, $3.7B
- PLSE – Pulse Biosciences Inc, $3.7B
- IRTC – iRhythm Technologies Inc, $3.6B
- OSIS – OSI Systems Inc, $3.1B
- ATRC – AtriCure Inc, $3B
- KN – Knowles Cor, $3B
- TMDX – TransMedics Group Inc, $2.5B
- BHC – Bausch Health Companies Inc, $2.4B
- UFPT – UFP Technologies Inc, $2.3B
- AXGN – Axogen Inc, $2.2B
- FTRE – Fortrea Holdings Inc., $2.1B
- INSP – Inspire Medical Systems Inc, $2B
- LMAT – LeMaitre Vascular Inc, $2B
- ESTA – Establishment Labs Holdings Inc, $1.8B
- BFLY – Butterfly Network Inc, $1.8B
- XRAY – Dentsply Sirona Inc, $1.8B
- NVCR – Novocure Ltd, $1.8B
- KMTS – Kestra Medical Technologies, Ltd. Common Stock, $1.7B
- CTS – CTS Corporation, $1.6B
- ATEC – Alphatec Holdings Inc, $1.6B
- OMCL – Omnicell Inc, $1.6B
- THRM – Gentherm Inc, $1.5B
- CNMD – CONMED Corporation, $1.3B
- DRTS – Alpha Tau Medical Ltd, $1.3B
- MNKD – MannKind Corp, $1.2B
- TNDM – Tandem Diabetes Care Inc, $1.1B
- IRMD – Iradimed Co, $1.1B
- AHG – Akso Health Group ADR, $1.1B
- STAA – STAAR Surgical Company, $1.1B
- AORT – Artivion Inc, $1.1B
- IART – Integra LifeSciences Holdings, $1B
- BBNX – Beta Bionics, Inc. Common Stock, $1B
- ENOV – Enovis Corp, $1B
- PCRX – Pacira BioSciences, Inc., $1B
- PRCT – Procept Biorobotics Corp, $983M
- BVS – Bioventus Inc, $897M
- CBLL – CeriBell, Inc, $888M
- QDEL – Quidel Corporation, $885M
- INMD – InMode Ltd, $811M
- SIBN – Si-Bone Inc, $810M
- SGP – SpyGlass Pharma, Inc., $792M
- VREX – Varex Imaging Corp, $784M
- AHCO – Adapthealth Corp, $770M
- CTKB – Cytek Biosciences Inc, $763M
- MLAB – Mesa Laboratories Inc, $722M
- KE – Kimball Electronics, $688M
- MDXG – MiMedx Group Inc, $670M
- AVR – Anteris Technologies Global Corp. Common Stock, $629M
- KIDS – Orthopediatrics Corp, $579M
- PACB – Pacific Biosciences of California, $572M
- DDD – 3D Systems Corporation, $557M
- SSII – SS Innovations International Inc. Common Stock, $541M
- DCTH – Delcath Systems Inc, $534M
- TCMD – Tactile Systems Technology Inc, $501M
- MASS – 908 Devices Inc, $498M
- XRN – Chiron Real Estate Inc., $494M
- NVEC – NVE Corporation, $494M
- MTLS – Materialise NV, $487M
- SENS – Senseonics Holdings, Inc. Common Stock, $484M
- BWAY – Brainsway Ltd, $474M
- ANGO – AngioDynamics Inc, $473M
- EOLS – Evolus Inc, $472M
- SGHT – Sight Sciences Inc, $467M
- CERS – Cerus Corporation, $459M
- NPCE – Neuropace Inc, $435M
- RCEL – Avita Medical Ltd, $404M
- MYGN – Myriad Genetics Inc, $396M
- CARL – Carlsmed, Inc., $390M
- SI – Shoulder Innovations, Inc., $390M
- EMBC – Embecta Corp, $389M
- OFIX – Orthofix Medical Inc, $367M
- CV – CapsoVision, Inc. Common Stock, $361M
- OBIO – Orchestra BioMed Holdings Inc., $358M
- VMD – Viemed Healthcare Inc, $355M
- EBS – Emergent Biosolutions Inc, $354M
- OPTX – Syntec Optics Holdings Inc., $327M
- SMTI – Sanara Medtech Inc, $320M
- ASPI – ASP Isotopes Inc. Common Stock, $315M
- MOBI – Mobia Medical, Inc. Common Stock, $287M
- CLPT – Clearpoint Neuro Inc, $277M
- MOVE – Movano Inc, $276M
- SY – So-Young International Inc, $273M
- LAB – Standard Biotools Inc, $263M
- INFU – InfuSystems Holdings Inc, $262M
- OSUR – OraSure Technologies Inc, $260M
- ANIK – Anika Therapeutics Inc, $256M
- TMCI – Treace Medical Concepts Inc, $252M
- TLSI – TriSalus Life Sciences Inc., $250M
- LFCR – Lifecore Biomedical Inc., $248M
- PROF – Profound Medical Corp, $242M
- UTMD – Utah Medical Products Inc, $237M
- ELMD – Electromed Inc, $231M
- FOCL – EDAP TMS S.A., $222M
- NNNN – Anbio Biotechnology Class A Ordinary Shares, $205M
- RXST – Rxsight Inc, $203M
- PDEX – Pro-Dex Inc, $202M
- XGN – Exagen Inc, $198M
- ORGO – Organogenesis Holdings Inc, $170M
- QTRX – Quanterix Corp, $163M
- STIM – Neuronetics Inc, $162M
- ZJYL – JIN MEDICAL INTERNATIONAL LTD. Ordinary Shares, $155M
- INGN – Inogen Inc, $154M
- OWLT – Owlet Inc, $138M
- KRMD – Repro Med Systems Inc, $136M
- NYXH – Nyxoah, $121M
- HUMA – Humacyte Inc, $119M
- LUCD – Lucid Diagnostics Inc, $116M
- SOTK – Sono-Tek Corp, $112M
- STXS – Stereotaxis Inc, $111M
- APYX – Apyx Medical Inc, $107M
- IMDX – Insight Molecular Diagnostics Inc., $107M
- VANI – Vivani Medical Inc., $104M
- ULBI – Ultralife Corporation, $103M
- RANI – Rani Therapeutics Holdings Inc, $103M
- HYPR – Hyperfine Inc, $98.7M
- CNXU – Conexeu Sciences Inc. Common Stock, $93.4M
- ECOR – Electrocore LLC, $87.6M
- NRXS – Neuraxis, Inc., $87M
- OM – Outset Medical Inc, $79.1M
- LUNG – Pulmonx Corp, $77.3M
- LNSR – LENSAR Inc, $77M
- SKIN – Beauty Health Co, $76.8M
- RFL – Rafael Holdings, Inc., $74.4M
- NTRB – Nutriband Inc, $73.5M
- MBOT – Microbot Medical Inc, $71.9M
- MDXH – MDxHealth SA, $63M
- DXR – Daxor Corporation, $58.9M
- TLPH – Talphera Inc., $55M
- MDAI – Spectral AI Inc., $53.1M
- RNXT – RenovoRx Inc, $52.4M
- COCH – Envoy Medical Inc., $50.9M
- MYO – Myomo Inc, $49.1M
- POCI – Precision Optics Corporation, Inc. Common stock, $48.9M
Showing the 200 largest of 299 members by market cap.